Ocular manifestations

Yes

No

Total

OR (IC 95%)

p value

N = 28

N = 25

Variables

n (%)

n (%)

n (%)

Sex

Male

15 (53.6)

13 (46.4)

28 (52.8)

1.07 (0.35 - 3.2)

0.560

Female

13 (52)

12 (48)

25 (47.2)

0.94 (0.31 - 2.83)

0.560

Age (ans)

[5 - 10]

9 (60)

6 (40)

15 (28.3)

1.5 (0.44 - 5.33)

0.360

[10 - 15]

10 (66.7)

5 (33.3)

15 (28.3)

2.22 (0.63 - 8.33)

0.170

[15 et + ]

9 (39.1)

14 (60.9)

23 (43.4)

0.37 (0.12 - 1.16)

0.070

Duration of treatment (years)

[0 - 5]

6 (75)

2 (25)

8 (15.1)

3.14 (0.58 - 24.16)

0.160

[5 - 10]

14 (53.8)

12 (46.2)

26 (49.1)

1.08 (0.36 - 3.26)

0.550

[10 et Plus]

8 (42.1)

11 (57.9)

19 (35.8)

0.51 (0.16 - 1.63)

0.190

CD4 (cell) count

[20 - 200]

2 (100)

0 (0)

2 (3.8)

-

0.270

[200 - 350]

2 (100)

0 (0)

2 (3.8)

-

0.270

[350 - 450]

3 (75)

1 (25)

4 (7.5)

2.88 (0.28 - 78.76)

0.350

[500 et + ]

21 (46.7)

24 (53.3)

45 (84.9)

0.13 (0.01 - 0.93)

0.040

Viral load (particles)

0

20 (57.1)

15 (42.9)

35 (66)

1.67 (0.52 - 5.4)

0.280

[1 - 100,001]

5 (45.5)

6 (54.5)

11 (20.8)

0.69 (0.17 - 2.74)

0.420

[10,001 - 50,000]

1 (33.3)

2 (66.7)

3 (5.7)

0.43 (0.01 - 6)

0.460

[50,001 et + ]

2 (50)

2 (50)

4 (7.5)

0.88 (0.09 - 9.09)

0.650